GSK plc Buys Back Own Shares
Ticker: GLAXF · Form: 6-K · Filed: Jun 16, 2025 · CIK: 1131399
| Field | Detail |
|---|---|
| Company | Gsk PLC (GLAXF) |
| Form Type | 6-K |
| Filed Date | Jun 16, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: share-buyback, stock-transaction
TL;DR
GSK is buying back its own stock via Merrill Lynch.
AI Summary
GSK plc announced on June 16, 2025, that it has purchased a number of its own ordinary shares through its corporate stockbroker, Merrill Lynch International. The filing does not specify the exact number of shares purchased or the total dollar amount involved in these transactions.
Why It Matters
Share buybacks can signal management's confidence in the company's valuation and potentially increase earnings per share.
Risk Assessment
Risk Level: low — This is a routine filing regarding share repurchases, which is common corporate activity.
Key Players & Entities
- GSK plc (company) — Filer of the report
- Merrill Lynch International (company) — Corporate stockbroker executing share purchases
- June 2025 (date) — Reporting period for the transaction
- June 16, 2025 (date) — Date of the announcement and transaction
FAQ
What is the total number of GSK plc ordinary shares purchased?
The filing states that GSK plc has purchased ordinary shares but does not specify the exact number.
What is the total dollar amount spent on the share repurchases?
The filing does not disclose the total dollar amount spent on the share repurchases.
Who is executing these share repurchases on behalf of GSK plc?
The share repurchases are being executed by Merrill Lynch International, acting as GSK plc's corporate stockbroker.
What is the par value of GSK plc's ordinary shares?
The ordinary shares of GSK plc have a par value of 31 1/4 pence each.
What is the purpose of this Form 6-K filing?
This Form 6-K filing is a report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, specifically reporting a transaction in own shares.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on June 16, 2025 regarding GSK plc (GLAXF).